24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Wake Forest
Medical School
Wake Forest University
Residency
Wake Forest University
Fellowship
American Board of Internal Medicine - Oncology
Saint Thomas - Rutherford Hospital
Languages: English/Spanish
(615) 396-4100
1700 Medical Center Pkwy
Murfreesboro, Tennessee 37129 
A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.
Burris, H. A.,Infante, J. R.,Anthony Greco, F.,Thompson, D. S.,Barton, J. H.,Bendell, J. C.,Nambu, Y.,Watanabe, N.,Jones, S. F.; Cancer Chemother. Pharmacol.. 1900 Jan 01.
See more >>
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory m...
Bendell, J. C.,Jones, S. F.,Hart, L.,Spigel, D. R.,Lane, C. M.,Earwood, C.,Infante, J. R.,Barton, J.,Burris, H. A.; Invest New Drugs. 2014 Oct 23.
See more >>
22 citations Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology...
Yardley DA, Burris HA, Clark BL, Shipley D, Rubin M, Barton J, Arrowsmith E, Hainsworth JD; Clin. Breast Cancer. 2011-06-01.
See more >>